Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
Chubb
Baxter
Daiichi Sankyo
Citi

Generated: April 19, 2019

DrugPatentWatch Database Preview

RITALIN LA Drug Profile

« Back to Dashboard

Which patents cover Ritalin La, and what generic alternatives are available?

Ritalin La is a drug marketed by Novartis and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.

This drug has one hundred and forty-two patent family members in thirty-three countries.

The generic ingredient in RITALIN LA is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.

Drug patent expirations by year for RITALIN LA
Pharmacology for RITALIN LA
Synonyms for RITALIN LA
.alpha.-Phenyl-2-piperidineacetic acid methyl ester
113-45-1
113-45-1 (Parent)
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester, hydrochloride
2-Piperidineacetic acid, alpha-phenyl-, methyl ester
2-Piperidineacetic acid, alpha-phenyl-, methyl ester, hydrochloride
2-Piperidineacetic acid, alpha-phenyl-, methyl ester, hydrochloride, (R*,R*)-(+-)-
298-59-9
298-59-9 (hydrochloride)
298M599
4311/B Ciba
AB01563134_01
AC1L1HJM
AC1L1SQ4
AC1Q5YRN
AKOS016010356
AKOS022506757
alpha-Phenyl-2-piperidineacetic acid methyl ester
alpha-phenyl-2-piperidineacetic acid methyl ester hydrochloride
alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester
AN-23356
API0003340
API0008866
BCP18286
BDBM50062912
BRD-A19585813-003-01-7
C 4311
C07196
Calocain
CAS-298-59-9
CC-30903
CCG-213572
CCRIS 6258
Centedein
Centedein (Salt/Mix)
Centedrin
Centedrin (Salt/Mix)
Centedrine
Centedrine (Salt/Mix)
Centredin
CHEBI:31836
CHEBI:84276
CHEMBL1722
CHEMBL796
ciba 4311b
Concerta
Concerta (TN)
Concerta, Methylin, Ritalin
Cotempla XR-ODT
CS-4657
CS-4658
d-methylphenidate HCl
D01296
D04999
Daytrana
Daytrana (TN)
DB00422
DEA No. 1724
DSSTox_CID_886
DSSTox_GSID_20886
DSSTox_RID_75843
DTXSID5023299
DTXSID8020886
DUGOZIWVEXMGBE-UHFFFAOYSA-N
EINECS 204-028-6
EINECS 206-065-3
FT-0603372
FT-0672046
FT-0672047
FT-0700534
GTPL7236
H-Tic-OtBu.HCl
HSDB 3126
HY-B1091
HY-B1091A
Jornay PM (a.k.a. HLD200)
JUMYIBMBTDDLNG-UHFFFAOYSA-N
L001307
LS-42
LS-565
Medikinet
Meridil
Meridil hydrochloride
Metadate
Metadate (TN)
Metadate CD
Metadate ER
Methyl .alpha.-phenyl-.alpha.-(2-piperidyl)acetate
Methyl .alpha.-phenyl-.alpha.-2-piperidinylacetate
Methyl .alpha.-phenyl-2-piperidine-acetate
Methyl .alpha.-phenyl-2-piperidineacetate
Methyl .alpha.-phenyl-2-piperidineacetate hydrochloride
Methyl (2-phenyl-2-(2-piperidyl)acetate)
methyl 2-phenyl-2-(2-piperidyl)acetate hydrochloride
Methyl 2-phenyl-2-(piperidin-2-yl)acetate
Methyl 2-phenyl-2-(piperidin-2-yl)acetate hydrochloride
methyl 2-phenyl-2-piperidin-2-ylacetate
methyl 2-phenyl-2-piperidin-2-ylacetate hydrochloride
methyl alpha-phenyl-2-piperidine-acetate hydrochloride
Methyl alpha-phenyl-2-piperidineacetate hydrochloride
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-2-piperidinylacetate
methyl alpha-piperid-2-ylphenylacetate
Methyl phenidate
Methyl phenidyl acetate
Methyl phenidylacetate
Methyl Phenidylacetate Hydrochloride
Methyl phenyl(2-piperidinyl)acetate #
methyl phenyl(piperidin-2-yl)acetate
methyl phenyl(piperidin-2-yl)acetate hydrochloride
Methylfenidan
Methylin
Methylin (Salt/Mix)
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidan Hydrochloride
methylphenidate
Methylphenidate (hydrochloride)
METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)
Methylphenidate (USAN/INN)
Methylphenidate [INN:BAN]
Methylphenidate [USAN:INN:BAN]
Methylphenidate HCl
METHYLPHENIDATE HYDROCHLORIDE
Methylphenidate hydrochloride (JAN/USP)
Methylphenidate hydrochloride [USAN:JAN]
Methylphenidate hydrochloride [USP:JAN]
Methylphenidate Hydrochloride ER
Methylphenidate hydrochloride solution, (Racemic mixture), ampule of 1 mL, 1.0 mg/mL in methanol (as free base), certified reference material
Methylphenidate hydrochloride, European Pharmacopoeia (EP) Reference Standard
Methylphenidate Hydrochloride(Ritalin hydrochloride)
METHYLPHENIDATE HYDROCHLORIDE(SEE ALSO: METHYLPHENIDATE, CAS 113-45-1, NTPNO M20344)
Methylphenidate.HCl
Methylphenidate(Ritalin)
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidylacetate hydrochloride
MethyPatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MLS003922100
NCGC00091942-01
NCGC00248587-01
NCGC00257863-01
NCI-C56280
NSC 169868
NSC-169868
NSC-759278
NSC169868
NSC759278
Pharmakon1600-01505907
Phenidylate
phenyl-piperidin-2-yl-acetic acid methyl ester
Plimasine
PMS-Methylphenidate
QuilliChew ER
Quillivant XR
Quillivant xr (TN)
Rilaline
Rilatine
Riphenidate
Ritalin
Ritalin (Salt/Mix)
Ritalin (TN)
Ritalin hy drochloride
Ritalin hydrochloride
Ritalin SR
Ritalin-SR
Ritaline
Ritaline (Salt/Mix)
Ritcher works
Rubifen
SBI-0206868.P001
SC-83308
SCHEMBL37178
SCHEMBL41067
SMR000058998
threo-Methyl |A-phenyl-|A-(2-piperidyl)acetate hydrochloride
Tox21_111186
Tox21_200309
TRANSGENIC MODEL EVALUATION (METHYLPHENIDATE HYDROCHLORIDE) (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE)
Tsentedrin
WLN: T6MTJ BYR & VO1 & GH

US Patents and Regulatory Information for RITALIN LA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis RITALIN LA methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284-004 Apr 10, 2004 AB1 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Novartis RITALIN LA methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284-003 Jun 5, 2002 AB1 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Novartis RITALIN LA methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284-001 Jun 5, 2002 AB1 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Novartis RITALIN LA methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284-002 Jun 5, 2002 AB1 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Novartis RITALIN LA methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284-005 Oct 27, 2014 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for RITALIN LA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis RITALIN LA methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284-004 Apr 10, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis RITALIN LA methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284-001 Jun 5, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis RITALIN LA methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284-001 Jun 5, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis RITALIN LA methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284-004 Apr 10, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis RITALIN LA methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284-003 Jun 5, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis RITALIN LA methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021284-003 Jun 5, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for RITALIN LA
Drugname Dosage Strength RLD Date
➤ Subscribe Extended-release Capsules 10 mg ➤ Subscribe ➤ Try a Free Trial
➤ Subscribe Extended-release Capsules 20 mg, 30 mg and 40 mg ➤ Subscribe ➤ Try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Mallinckrodt
Colorcon
Julphar
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.